Wall Street Pulls Back on Novo Nordisk and Jefferies
Stocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
158 articlesEvaxion (EVAX) 2025 Earnings Outlook and Analysis.
A practical, reader-friendly guide to what to expect in evaxion (evax) 2025 earnings. Learn the drivers, read the cal...
Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Buying This Biotech Stock Could Grow Your Retirement Wealth
Biotech stocks offer exciting growth potential, but with high risk. This guide explains how buying this biotech stock...
TransMedics Stock 104% Over: Is 2026 the Next Breakout?
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
Reasons Boston Scientific Stock Could Quietly 5X Over Time
As the world ages, demand for life-saving medical devices grows. This article breaks down three pragmatic reasons why...
Investment Firm Bets TNGX: A Big $9.5 Million Market Bet
A major fund just disclosed a sizable stake in Tango Therapeutics (TNGX), totaling about $9.5 million. This move shin...
Arcturus (ARCT) 2025 Earnings Guide for Investors
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Is Crispr Therapeutics Stock Risky Right Now? A Practical Guide for Investors
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Compugen (CGEN) 2025 Earnings Outlook for Investors
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Related Topics
#Investing (126)
#Stock Analysis (39)
#Earnings Analysis (28)
#Insider Trading (22)
#Stock Market (16)
#Stock Market News (16)
#Earnings (14)
#Portfolio Strategy (12)
#Portfolio Management (11)
#Investing Strategy (9)
#SEC Filings (7)
#risk-management (6)
#Hedge Funds (6)
#CRISPR (6)
#Pharmaceuticals (5)